← 產業報告目錄

Dried Blood Spot Testing Market Research Report by Card Type (Whatman 903, Ahlstrom 226, FTA, Others), by Technology (Elution-Based Testing, Direct Testing Techniques), by Application (Newborn Screening (NBS), Infectious Diseases Testing, Forensics, Therapeutic Drug Monitoring, Others), by End User (Hospital and Clinics, Diagnostic Laboratories, Academic Institutions, Others), and by Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) Forecast till 2036

出版商 Market Research Future產業別 Healthcare & Life Sciences出版日期 2026-04-03頁數 174報告編號 MRFRHC66556CR

授權報價

Single User Price$4,950 USD
Multi User Licence (up to 10 users)$5,950 USD
Enterprisewide Price (Global Site License)$7,250 USD
洽詢購買 申請 Sample

報告摘要

The global dried blood spot testing market is projected to grow from USD 476.03 million in 2025 to USD 810.51 million by 2036, registering a CAGR of 4.92% over the forecast period. This steady growth reflects increasing adoption of minimally invasive diagnostic methods and expanding applications in clinical and research settings. Increasing Role of Forensic Toxicology in Drug Detection The increasing problem of drug abuse worldwide and the sudden arrival of synthetic opioids are two major factors that are greatly increasing the need for advanced forensic toxicology solutions. This in turn is leading to the positioning of dried blood spot (DBS) testing as an essential method for large-scale screening. Its feature of producing reliable results from a tiny amount of sample makes it highly efficient especially in clinical and forensic investigations. Concise Segment-Wise Market Snapshot Card Type • Whatman 903: Widely used standard filter paper card • Ahlstrom 226: High-quality alternative with strong absorption • FTA: Chemically treated cards for DNA preservation • Others: Includes niche and emerging card variants Technology • Elution-Based Testing: Traditional extraction-based analytical testing method • Direct Testing Techniques: Faster methods without sample extraction Application • Newborn Screening (NBS): Early detection of congenital disorders • Infectious Diseases Testing: Identifies viral and bacterial infections • Forensics: Drug detection and toxicology investigations • Therapeutic Drug Monitoring: Tracks drug levels for treatment efficacy • Others: Covers additional clinical and research uses End User • Hospital and Clinics: Primary settings for sample collection • Diagnostic Laboratories: Central hubs for DBS sample analysis • Academic Institutions: Research-driven applications and method development • Others: Includes CROs and specialized healthcare facilities North America is leading the market on the basis of its robust healthcare system and numerous screening programs while Europe follows as its adoption is primarily driven by regulations and a greater focus on preventive care. Asia Pacific is the most dynamic player showing growth as it is attracting investments and the governments there are also launching many initiatives, on the other hand the South America and Middle East and Africa markets are expanding at a steady but moderate pace. Strategic Capacity Expansion Enhancing DBS Capabilities On June 2025, Salimetrics LLC increased their Core Lab output by double their dried blood spot (DBS) assay services while reducing analysis processing time by 50%. This step has very significantly made clinical and academic research more easily accessible, allowing faster, high-volume testing and the analysis of a wider range of biomarkers through the use of minimally invasive sampling. Rising Adoption of Home-Based Diagnostic Models The market could gain a significant competitive advantage by exploiting the ongoing changes to home-based and decentralized testing, which will not only provide better patient access but also lower the cost of healthcare and increase the efficiency of the diagnostic process. Large-scale deployment of DBS-based self-collection solutions is being propelled along by the increasing consumer desire and high adoption rate, which are also backed by strong clinical validation. Key Report Attributes • Market Size 2025: USD 476.03 Million • Market Size 2036: USD 810.51 Million • CAGR (2025-2036): 4.92% • Base Year: 2024 • Market Forecast Period: 2025-2036 Industry Segmentations Growth • By Card Type: Whatman 903 - 4.29%, Ahlstrom 226 - 4.86%. • By Technology: Elution-Based Testing - 4.82%, Direct Testing Techniques - 5.90%. • By Application: Newborn Screening (NBS) - 4.86%, Infectious Diseases Testing - 5.01%. • By End User: Hospital and Clinics - 4.66%, Diagnostic Laboratories - 5.46%.
目錄 Table of Contents
TABLE OF CONTENTS 1 EXECUTIVE SUMMARY ...... 19 1.1 OVERVIEW .......... 19 1.2 MARKET ATTRACTIVENESS ANALYSIS ......... 20 1.3 GLOBAL DRIED BLOOD SPOT TESTING MARKET, BY CARD TYPE ........... 21 1.4 GLOBAL DRIED BLOOD SPOT TESTING MARKET, BY TECHNOLOGY ...... 22 1.5 GLOBAL DRIED BLOOD SPOT TESTING MARKET, BY APPLICATION ...... 23 1.6 GLOBAL DRIED BLOOD SPOT TESTING MARKET, BY END USER ....... 24 1.7 GLOBAL DRIED BLOOD SPOT TESTING MARKET, BY REGION ..... 25 2 MARKET INTRODUCTION .......... 27 2.1 DEFINITION ........ 27 2.2 SCOPE OF THE STUDY ......... 27 2.3 RESEARCH OBJECTIVE ....... 27 2.4 MARKET STRUCTURE ......... 27 3 RESEARCH METHODOLOGY ........... 28 3.1 OVERVIEW .......... 28 3.2 DATA FLOW ........ 30 3.2.1 Data Mining Process ......... 30 3.3 PURCHASED DATABASE: ........... 31 3.4 SECONDARY SOURCES: ....... 32 3.4.1 Secondary Research data flow: ........ 33 3.5 PRIMARY RESEARCH: .......... 34 3.5.1 Primary Research Data Flow: .......... 35 3.5.2 Primary Research: Number of Interviews conducted ........... 36 3.6 APPROACHES FOR MARKET SIZE ESTIMATION: ....... 37 3.6.1 Revenue Analysis Approach ..... 37 3.7 DATA FORECASTING..... 38 3.7.1 Data forecasting Type ....... 38 3.8 DATA MODELING ..... 39 3.8.1 microeconomic factor analysis: ....... 39 3.8.2 Data modeling: .......... 40 3.9 TEAMS AND ANALYST CONTRIBUTION ......... 42 4 MARKET DYNAMICS ........... 44 4.1 INTRODUCTION ........ 44 4.2 DRIVERS ........ 45 4.2.1 Rising Prevalence of Chronic & Infectious Diseases ...... 45 4.2.2 Increasing Newborn Screening Programs Globally ........ 45 4.2.3 Increasing Forensic Toxicology Applications ......... 46 4.3 RESTRAINTS ...... 48 4.3.1 Variability & Standardization Challenges ........ 48 4.3.2 Regulatory & Quality Control Hurdles ...... 48 4.4 OPPORTUNITIES ...... 50 4.4.1 Expansion of Home-Based and Decentralized Testing Models ..... 50 4.4.2 Increasing Role in Personalized Medicine & Clinical Research ..... 51 5 MARKET FACTOR ANALYSIS ........... 52 5.1 PORTER'S FIVE FORCES MODEL ........... 52 5.1.1 Threat of New Entrants ..... 52 5.1.2 Bargaining Power of Suppliers ......... 53 5.1.3 Threat of Substitutes ........ 53 5.1.4 Bargaining Power of Buyers ..... 54 5.1.5 Intensity of Rivalry ..... 54 5.2 REGULATORY ENVIRONMENT & COMPLIANCE ......... 54 5.3 PRODUCT PRICING ANALYSIS ........ 56 5.3.1 North America Pricing Analysis ....... 56 5.3.2 Europe Pricing Analysis ........... 56 5.3.3 Asia-Pacific Pricing Analysis ........... 56 5.3.4 South America Pricing Analysis ....... 57 5.3.5 Middle East & Africa Pricing Analysis...... 57 5.4 MARKET TREND ANALYSIS ........... 57 5.5 MARKET ENTRY/EXIT STRATEGIES ......... 59 5.6 PESTEL ANALYSIS ......... 60 6 GLOBAL DRIED BLOOD SPOT TESTING MARKET, BY CARD TYPE ...... 63 6.1 OVERVIEW .......... 63 6.2 903 CARDS ........... 64 6.3 226 CARDS ........... 65 6.4 FTA CARDS ......... 65 6.5 OTHERS ......... 66 7 GLOBAL DRIED BLOOD SPOT TESTING MARKET, BY TECHNOLOGY ........ 67 7.1 OVERVIEW .......... 67 7.2 ELUTION-BASED TESTING ........ 68 7.3 DIRECT TESTING TECHNIQUES ..... 69 8 GLOBAL DRIED BLOOD SPOT TESTING MARKET, BY APPLICATION.......... 70 8.1 OVERVIEW .......... 70 8.2 NEWBORN SCREENING (NBS) ......... 72 8.3 INFECTIOUS DISEASES TESTING ......... 72 8.4 FORENSICS .......... 73 8.5 THERAPEUTIC DRUG MONITORING ........... 73 8.6 OTHERS ......... 74 9 GLOBAL DRIED BLOOD SPOT TESTING MARKET, BY END USER ........ 75 9.1 OVERVIEW .......... 75 9.2 HOSPITAL AND CLINICS ..... 77 9.3 DIAGNOSTIC LABORATORIES ......... 77 9.4 ACADEMIC INSTITUTIONS ....... 78 9.5 OTHERS ......... 78 10 GLOBAL DRIED BLOOD SPOT TESTING MARKET, BY REGION ..... 80 10.1 OVERVIEW .......... 80 10.2 NORTH AMERICA ........... 82 10.2.1 US........ 85 10.2.2 Canada ....... 86 10.3 EUROPE ......... 88 10.3.1 Germany ..... 91 10.3.2 UK ....... 93 10.3.3 France ........ 94 10.3.4 Italy ..... 96 10.3.5 Spain .......... 97 10.3.6 Rest of Europe ........... 99 10.4 ASIA PACIFIC ..... 101 10.4.1 China .......... 104 10.4.2 India ........... 106 10.4.3 Japan ......... 108 10.4.4 South Korea ....... 109 10.4.5 Malaysia ..... 111 10.4.6 Thailand ...... 112 10.4.7 Indonesia ........... 114 10.4.8 Rest of Asia Pacific .......... 116 10.5 SOUTH AMERICA ........... 118 10.5.1 Brazil .......... 121 10.5.2 Mexico ........ 123 10.5.3 Argentina ........... 125 10.5.4 Rest of South America ...... 127 10.6 MIDDLE EAST AND AFRICA ...... 130 10.6.1 GCC Countries ........... 133 10.6.2 South Africa ....... 135 10.6.3 Rest of Middle East and Africa ........ 137 11 COMPETITIVE LANDSCAPE ...... 141 11.1 INTRODUCTION ........ 141 11.2 MARKET SHARE ANALYSIS, 2025 ....... 141 11.3 COMPETITOR DASHBOARD....... 142 11.4 PUBLIC PLAYERS STOCK SUMMARY ........ 143 11.5 COMPARATIVE ANALYSIS: KEY PLAYERS FINANCIAL ........ 143 11.6 KEY DEVELOPMENTS & GROWTH STRATEGIES ........ 144 11.6.1 Acquisition ......... 144 11.6.2 Product launch .......... 144 11.6.3 Expansion .......... 144 12 COMPANY PROFILES ......... 145 12.1 AHLSTROM OYJ ....... 145 12.1.1 COMPANY OVERVIEW ....... 145 12.1.2 FINANCIAL OVERVIEW ...... 146 12.1.3 PRODUCTS OFFERED ........ 147 12.1.4 KEY DEVELOPMENTS ........ 147 12.1.5 SWOT ANALYSIS ....... 147 12.1.6 KEY STRATEGY .......... 148 12.2 REVVITY INC ..... 149 12.2.1 COMPANY OVERVIEW ....... 149 12.2.2 FINANCIAL OVERVIEW ...... 150 12.2.3 PRODUCTS OFFERED ........ 150 12.2.4 KEY DEVELOPMENTS ........ 151 12.2.5 SWOT ANALYSIS ....... 151 12.2.6 KEY STRATEGIES ....... 151 12.3 ARCHIMEDLIFE GMBH ........ 153 12.3.1 COMPANY OVERVIEW ....... 153 12.3.2 FINANCIAL OVERVIEW ...... 153 12.3.3 PRODUCTS OFFERED ........ 154 12.3.4 KEY DEVELOPMENTs ........ 154 12.3.5 KEY STRATEGIES ....... 154 12.4 QIAGEN .......... 155 12.4.1 COMPANY OVERVIEW ....... 155 12.4.2 FINANCIAL OVERVIEW ...... 156 12.4.3 PRODUCTS OFFERED ........ 156 12.4.4 KEY DEVELOPMENTS ........ 156 12.4.5 SWOT ANALYSIS ....... 157 12.4.6 KEY STRATEGIES ....... 157 12.5 EASTERN BUSINESS FORMS, INC. ........ 158 12.5.1 COMPANY OVERVIEW ....... 158 12.5.2 FINANCIAL OVERVIEW ...... 158 12.5.3 PRODUCTS OFFERED ........ 159 12.5.4 KEY DEVELOPMENTS ........ 159 12.5.5 SWOT ANALYSIS ....... 159 12.5.6 KEY STRATEGIES ....... 160 12.6 RDA SPOT INC. .......... 161 12.6.1 COMPANY OVERVIEW ....... 161 12.6.2 FINANCIAL OVERVIEW ...... 161 12.6.3 PRODUCTS OFFERED ........ 162 12.6.4 KEY DEVELOPMENTS ........ 162 12.6.5 KEY STRATEGIES ....... 162 12.7 SALIMETRICS, LLC. ........ 163 12.7.1 COMPANY OVERVIEW ....... 163 12.7.2 FINANCIAL OVERVIEW ...... 163 12.7.3 PRODUCTS OFFERED ........ 164 12.7.4 KEY DEVELOPMENTS ........ 164 12.7.5 KEY STRATEGIES ....... 164 12.8 CYTIVA .......... 165 12.8.1 COMPANY OVERVIEW ....... 165 12.8.2 FINANCIAL OVERVIEW ...... 165 12.8.3 PRODUCTS OFFERED ........ 166 12.8.4 KEY DEVELOPMENTS ........ 166 12.8.5 SWOT ANALYSIS ....... 166 12.8.6 KEY STRATEGIES ....... 167 12.9 CENTOGENE GMBH ....... 168 12.9.1 COMPANY OVERVIEW ....... 168 12.9.2 FINANCIAL OVERVIEW ...... 169 12.9.3 PRODUCTS OFFERED ........ 169 12.9.4 KEY DEVELOPMENTS ........ 169 12.9.5 KEY STRATEGIES ....... 169 12.10 NEOTERYX, LLC ....... 170 12.10.1 COMPANY OVERVIEW ....... 170 12.10.2 FINANCIAL OVERVIEW ...... 170 12.10.3 PRODUCTS OFFERED ........ 171 12.10.4 KEY DEVELOPMENTS ........ 171 12.10.5 KEY STRATEGIES ....... 171 13 DATA CITATIONS ......... 172
圖表清單 List of Tables & Figures
LIST OF TABLES TABLE 1 QFD MODELING FOR MARKET SHARE ASSESSMENT 41 TABLE 2 GLOBAL DRIED BLOOD SPOT TESTING MARKET, BY CARD TYPE, 2019–2036 (USD MILLION) 64 TABLE 3 GLOBAL DRIED BLOOD SPOT TESTING MARKET, FOR 903 CARDS, BY REGION, 2019–2036 (USD MILLION) 64 TABLE 4 GLOBAL DRIED BLOOD SPOT TESTING MARKET, FOR 226 CARDS, BY REGION, 2019–2036 (USD MILLION) 65 TABLE 5 GLOBAL DRIED BLOOD SPOT TESTING MARKET, FOR FTA CARDS, BY REGION, 2019–2036 (USD MILLION) 65 TABLE 6 GLOBAL DRIED BLOOD SPOT TESTING MARKET, FOR OTHERS, BY REGION, 2019–2036 (USD MILLION) 66 TABLE 7 GLOBAL DRIED BLOOD SPOT TESTING MARKET, BY TECHNOLOGY, 2019–2036 (USD MILLION) 68 TABLE 8 GLOBAL DRIED BLOOD SPOT TESTING MARKET, FOR ELUTING-BASED TESTING, BY REGION, 2019–2036 (USD MILLION) 68 TABLE 9 GLOBAL DRIED BLOOD SPOT TESTING MARKET, FOR DIREST TESTING TECHNIQUES, BY REGION, 2019–2036 (USD MILLION) 69 TABLE 10 GLOBAL DRIED BLOOD SPOT TESTING MARKET, BY APPLICATION, 2019–2036 (USD MILLION) 71 TABLE 11 GLOBAL DRIED BLOOD SPOT TESTING MARKET, FOR NEWBORN SCREENING (NBS), BY REGION, 2019–2036 (USD MILLION) 72 TABLE 12 GLOBAL DRIED BLOOD SPOT TESTING MARKET, FOR INFECTIOUS DISEASES TESTING, BY REGION, 2019–2036 (USD MILLION) 72 TABLE 13 GLOBAL DRIED BLOOD SPOT TESTING MARKET, FOR FORENSICS, BY REGION, 2019–2036 (USD MILLION) 73 TABLE 14 GLOBAL DRIED BLOOD SPOT TESTING MARKET, FOR THERAPEUTIC DRUG MONITORING, BY REGION, 2019–2036 (USD MILLION) 73 TABLE 15 GLOBAL DRIED BLOOD SPOT TESTING MARKET, FOR OTHERS, BY REGION, 2019–2036 (USD MILLION) 74 TABLE 16 GLOBAL DRIED BLOOD SPOT TESTING MARKET, BY END USER, 2019–2036 (USD MILLION) 76 TABLE 17 GLOBAL DRIED BLOOD SPOT TESTING MARKET, FOR HOSPITAL AND CLINICS, BY REGION, 2019–2036 (USD MILLION) 77 TABLE 18 GLOBAL DRIED BLOOD SPOT TESTING MARKET, FOR DIAGNOSTIC LABORATORIES, BY REGION, 2019–2036 (USD MILLION) 77 TABLE 19 GLOBAL DRIED BLOOD SPOT TESTING MARKET, FOR ACADEMIC INSTITUTIONS, BY REGION, 2019–2036 (USD MILLION) 78 TABLE 20 GLOBAL DRIED BLOOD SPOT TESTING MARKET, FOR OTHERS, BY REGION, 2019–2036 (USD MILLION) 78 TABLE 21 GLOBAL DRIED BLOOD SPOT TESTINGS MARKET, BY REGION, 2019-2036 (USD MILLION) 81 TABLE 22 NORTH AMERICA DRIED BLOOD SPOT TESTING MARKET, BY COUNTRY, 2019-2036 (USD MILLION) 83 TABLE 23 NORTH AMERICA DRIED BLOOD SPOT TESTING MARKET, BY CARD TYPE, 2019-2036 (USD MILLION) 83 TABLE 24 NORTH AMERICA DRIED BLOOD SPOT TESTING MARKET, BY TECHNOLOGY, 2019-2036 (USD MILLION) 84 TABLE 25 NORTH AMERICA DRIED BLOOD SPOT TESTING MARKET, BY APPLICATION, 2019-2036 (USD MILLION) 84 TABLE 26 NORTH AMERICA DRIED BLOOD SPOT TESTING MARKET, BY END USER, 2019-2036 (USD MILLION) 84 TABLE 27 US DRIED BLOOD SPOT TESTING MARKET, BY CARD TYPE, 2019-2036 (USD MILLION) 85 TABLE 28 US DRIED BLOOD SPOT TESTING MARKET, BY TECHNOLOGY, 2019-2036 (USD MILLION) 85 TABLE 29 US DRIED BLOOD SPOT TESTING MARKET, BY APPLICATION, 2019-2036 (USD MILLION) 85 TABLE 30 US DRIED BLOOD SPOT TESTING MARKET, BY END USER, 2019-2036 (USD MILLION) 86 TABLE 31 CANADA DRIED BLOOD SPOT TESTING MARKET, BY CARD TYPE, 2019-2036 (USD MILLION) 86 TABLE 32 CANADA DRIED BLOOD SPOT TESTING MARKET, BY TECHNOLOGY, 2019-2036 (USD MILLION) 87 TABLE 33 CANADA DRIED BLOOD SPOT TESTING MARKET, BY APPLICATION, 2019-2036 (USD MILLION) 87 TABLE 34 CANADA DRIED BLOOD SPOT TESTING MARKET, BY END USER, 2019-2036 (USD MILLION) 87 TABLE 35 EUROPE DRIED BLOOD SPOT TESTING MARKET, BY COUNTRY, 2019-2036 (USD MILLION) 89 TABLE 36 EUROPE DRIED BLOOD SPOT TESTING MARKET, BY CARD TYPE, 2019-2036 (USD MILLION) 89 TABLE 37 EUROPE DRIED BLOOD SPOT TESTING MARKET, BY TECHNOLOGY, 2019-2036 (USD MILLION) 90 TABLE 38 EUROPE DRIED BLOOD SPOT TESTING MARKET, BY APPLICATION, 2019-2036 (USD MILLION) 90 TABLE 39 EUROPE DRIED BLOOD SPOT TESTING MARKET, BY END USER, 2019-2036 (USD MILLION) 91 TABLE 40 GERMANY DRIED BLOOD SPOT TESTING MARKET, BY CARD TYPE, 2019-2036 (USD MILLION) 91 TABLE 41 GERMANY DRIED BLOOD SPOT TESTING MARKET, BY TECHNOLOGY, 2019-2036 (USD MILLION) 91 TABLE 42 GERMANY DRIED BLOOD SPOT TESTING MARKET, BY APPLICATION, 2019-2036 (USD MILLION) 92 TABLE 43 GERMANY DRIED BLOOD SPOT TESTING MARKET, BY END USER, 2019-2036 (USD MILLION) 92 TABLE 44 UK DRIED BLOOD SPOT TESTING MARKET, BY CARD TYPE, 2019-2036 (USD MILLION) 93 TABLE 45 UK DRIED BLOOD SPOT TESTING MARKET, BY TECHNOLOGY, 2019-2036 (USD MILLION) 93 TABLE 46 UK DRIED BLOOD SPOT TESTING MARKET, BY APPLICATION, 2019-2036 (USD MILLION) 93 TABLE 47 UK DRIED BLOOD SPOT TESTING MARKET, BY END USER, 2019-2036 (USD MILLION) 94 TABLE 48 FRANCE DRIED BLOOD SPOT TESTING MARKET, BY CARD TYPE, 2019-2036 (USD MILLION) 94 TABLE 49 FRANCE DRIED BLOOD SPOT TESTING MARKET, BY TECHNOLOGY, 2019-2036 (USD MILLION) 95 TABLE 50 FRANCE DRIED BLOOD SPOT TESTING MARKET, BY APPLICATION, 2019-2036 (USD MILLION) 95 TABLE 51 FRANCE DRIED BLOOD SPOT TESTING MARKET, BY END USER, 2019-2036 (USD MILLION) 95 TABLE 52 ITALY DRIED BLOOD SPOT TESTING MARKET, BY CARD TYPE, 2019-2036 (USD MILLION) 96 TABLE 53 ITALY DRIED BLOOD SPOT TESTING MARKET, BY TECHNOLOGY, 2019-2036 (USD MILLION) 96 TABLE 54 ITALY DRIED BLOOD SPOT TESTING MARKET, BY APPLICATION, 2019-2036 (USD MILLION) 96 TABLE 55 ITALY DRIED BLOOD SPOT TESTING MARKET, BY END USER, 2019-2036 (USD MILLION) 97 TABLE 56 SPAIN DRIED BLOOD SPOT TESTING MARKET, BY CARD TYPE, 2019-2036 (USD MILLION) 97 TABLE 57 SPAIN DRIED BLOOD SPOT TESTING MARKET, BY TECHNOLOGY, 2019-2036 (USD MILLION) 98 TABLE 58 SPAIN DRIED BLOOD SPOT TESTING MARKET, BY APPLICATION, 2019-2036 (USD MILLION) 98 TABLE 59 SPAIN DRIED BLOOD SPOT TESTING MARKET, BY END USER, 2019-2036 (USD MILLION) 98 TABLE 60 REST OF EUROPE DRIED BLOOD SPOT TESTING MARKET, BY CARD TYPE, 2019-2036 (USD MILLION) 99 TABLE 61 REST OF EUROPE DRIED BLOOD SPOT TESTING MARKET, BY TECHNOLOGY, 2019-2036 (USD MILLION) 99 TABLE 62 REST OF EUROPE DRIED BLOOD SPOT TESTING MARKET, BY APPLICATION, 2019-2036 (USD MILLION) 99 TABLE 63 REST OF EUROPE DRIED BLOOD SPOT TESTING MARKET, BY END USER, 2019-2036 (USD MILLION) 100 TABLE 64 ASIA PACIFIC DRIED BLOOD SPOT TESTING MARKET, BY COUNTRY, 2019-2036 (USD MILLION) 102 TABLE 65 ASIA PACIFIC DRIED BLOOD SPOT TESTING MARKET, BY CARD TYPE, 2019-2036 (USD MILLION) 103 TABLE 66 ASIA PACIFIC DRIED BLOOD SPOT TESTING MARKET, BY TECHNOLOGY, 2019-2036 (USD MILLION) 103 TABLE 67 ASIA PACIFIC DRIED BLOOD SPOT TESTING MARKET, BY APPLICATION, 2019-2036 (USD MILLION) 103 TABLE 68 ASIA PACIFIC DRIED BLOOD SPOT TESTING MARKET, BY END USER, 2019-2036 (USD MILLION) 104 TABLE 69 CHINA DRIED BLOOD SPOT TESTING MARKET, BY CARD TYPE, 2019-2036 (USD MILLION) 104 TABLE 70 CHINA DRIED BLOOD SPOT TESTING MARKET, BY TECHNOLOGY, 2019-2036 (USD MILLION) 105 TABLE 71 CHINA DRIED BLOOD SPOT TESTING MARKET, BY APPLICATION, 2019-2036 (USD MILLION) 105 TABLE 72 CHINA DRIED BLOOD SPOT TESTING MARKET, BY END USER, 2019-2036 (USD MILLION) 105 TABLE 73 INDIA DRIED BLOOD SPOT TESTING MARKET, BY CARD TYPE, 2019-2036 (USD MILLION) 106 TABLE 74 INDIA DRIED BLOOD SPOT TESTING MARKET, BY TECHNOLOGY, 2019-2036 (USD MILLION) 106 TABLE 75 INDIA DRIED BLOOD SPOT TESTING MARKET, BY APPLICATION, 2019-2036 (USD MILLION) 107 TABLE 76 INDIA DRIED BLOOD SPOT TESTING MARKET, BY END USER, 2019-2036 (USD MILLION) 107 TABLE 77 JAPAN DRIED BLOOD SPOT TESTING MARKET, BY CARD TYPE, 2019-2036 (USD MILLION) 108 TABLE 78 JAPAN DRIED BLOOD SPOT TESTING MARKET, BY TECHNOLOGY, 2019-2036 (USD MILLION) 108 TABLE 79 JAPAN DRIED BLOOD SPOT TESTING MARKET, BY APPLICATION, 2019-2036 (USD MILLION) 108 TABLE 80 JAPAN DRIED BLOOD SPOT TESTING MARKET, BY END USER, 2019-2036 (USD MILLION) 109 TABLE 81 SOUTH KOREA DRIED BLOOD SPOT TESTING MARKET, BY CARD TYPE, 2019-2036 (USD MILLION) 109 TABLE 82 SOUTH KOREA DRIED BLOOD SPOT TESTING MARKET, BY TECHNOLOGY, 2019-2036 (USD MILLION) 110 TABLE 83 SOUTH KOREA DRIED BLOOD SPOT TESTING MARKET, BY APPLICATION, 2019-2036 (USD MILLION) 110 TABLE 84 SOUTH KOREA DRIED BLOOD SPOT TESTING MARKET, BY END USER, 2019-2036 (USD MILLION) 110 TABLE 85 MALAYSIA DRIED BLOOD SPOT TESTING MARKET, BY CARD TYPE, 2019-2036 (USD MILLION) 111 TABLE 86 MALAYSIA DRIED BLOOD SPOT TESTING MARKET, BY TECHNOLOGY, 2019-2036 (USD MILLION) 111 TABLE 87 MALAYSIA DRIED BLOOD SPOT TESTING MARKET, BY APPLICATION, 2019-2036 (USD MILLION) 111 TABLE 88 MALAYSIA DRIED BLOOD SPOT TESTING MARKET, BY END USER, 2019-2036 (USD MILLION) 112 TABLE 89 THAILAND DRIED BLOOD SPOT TESTING MARKET, BY CARD TYPE, 2019-2036 (USD MILLION) 112 TABLE 90 THAILAND DRIED BLOOD SPOT TESTING MARKET, BY TECHNOLOGY, 2019-2036 (USD MILLION) 113 TABLE 91 THAILAND DRIED BLOOD SPOT TESTING MARKET, BY APPLICATION, 2019-2036 (USD MILLION) 113 TABLE 92 THAILAND DRIED BLOOD SPOT TESTING MARKET, BY END USER, 2019-2036 (USD MILLION) 113 TABLE 93 INDONESIA DRIED BLOOD SPOT TESTING MARKET, BY CARD TYPE, 2019-2036 (USD MILLION) 114 TABLE 94 INDONESIA DRIED BLOOD SPOT TESTING MARKET, BY TECHNOLOGY, 2019-2036 (USD MILLION) 114 TABLE 95 INDONESIA DRIED BLOOD SPOT TESTING MARKET, BY APPLICATION, 2019-2036 (USD MILLION) 115 TABLE 96 INDONESIA DRIED BLOOD SPOT TESTING MARKET, BY END USER, 2019-2036 (USD MILLION) 115 TABLE 97 REST OF ASIA PACIFIC DRIED BLOOD SPOT TESTING MARKET, BY CARD TYPE, 2019-2036 (USD MILLION) 116 TABLE 98 REST OF ASIA PACIFIC DRIED BLOOD SPOT TESTING MARKET, BY TECHNOLOGY, 2019-2036 (USD MILLION) 116 TABLE 99 REST OF ASIA PACIFIC DRIED BLOOD SPOT TESTING MARKET, BY APPLICATION, 2019-2036 (USD MILLION) 117 TABLE 100 REST OF ASIA PACIFIC DRIED BLOOD SPOT TESTING MARKET, BY END USER, 2019-2036 (USD MILLION) 117 TABLE 101 SOUTH AMERICA DRIED BLOOD SPOT TESTING MARKET, BY COUNTRY, 2019-2036 (USD MILLION) 119 TABLE 102 SOUTH AMERICA DRIED BLOOD SPOT TESTING MARKET , BY CARD TYPE, 2019–2036 (USD MILLION) 119 TABLE 103 SOUTH AMERICA: DRIED BLOOD SPOT TESTING MARKET , BY TECHNOLOGY, 2019–2036 (USD MILLION) 120 TABLE 104 SOUTH AMERICA: DRIED BLOOD SPOT TESTING MARKET , BY APPLICATION, 2019–2036 (USD MILLION) 120 TABLE 105 SOUTH AMERICA: DRIED BLOOD SPOT TESTING MARKET , BY END USER, 2019–2036 (USD MILLION) 121 TABLE 106 BRAZIL DRIED BLOOD SPOT TESTING MARKET , BY CARD TYPE, 2019–2036 (USD MILLION) 121 TABLE 107 BRAZIL: DRIED BLOOD SPOT TESTING MARKET , BY TECHNOLOGY, 2019–2036 (USD MILLION) 122 TABLE 108 BRAZIL: DRIED BLOOD SPOT TESTING MARKET , BY APPLICATION, 2019–2036 (USD MILLION) 122 TABLE 109 BRAZIL: DRIED BLOOD SPOT TESTING MARKET , BY END USER, 2019–2036 (USD MILLION) 123 TABLE 110 MEXICO:DRIED BLOOD SPOT TESTING MARKET , BY CARD TYPE, 2019–2036 (USD MILLION) 123 TABLE 111 MEXICO: DRIED BLOOD SPOT TESTING MARKET , BY TECHNOLOGY, 2019–2036 (USD MILLION) 124 TABLE 112 MEXICO: DRIED BLOOD SPOT TESTING MARKET , BY APPLICATION, 2019–2036 (USD MILLION) 124 TABLE 113 MEXICO: DRIED BLOOD SPOT TESTING MARKET , BY END USER, 2019–2036 (USD MILLION) 125 TABLE 114 ARGENTINA: DRIED BLOOD SPOT TESTING MARKET , BY CARD TYPE, 2019–2036 (USD MILLION) 125 TABLE 115 ARGENTINA: DRIED BLOOD SPOT TESTING MARKET , BY TECHNOLOGY, 2019–2036 (USD MILLION) 126 TABLE 116 ARGENTINA: DRIED BLOOD SPOT TESTING MARKET , BY APPLICATION, 2019–2036 (USD MILLION) 126 TABLE 117 ARGENTINA: DRIED BLOOD SPOT TESTING MARKET , BY END USER, 2019–2036 (USD MILLION) 127 TABLE 118 REST OF SOUTH AMERICA: DRIED BLOOD SPOT TESTING MARKET, BY CARD TYPE, 2019–2036 (USD MILLION) 127 TABLE 119 REST OF SOUTH AMERICA: DRIED BLOOD SPOT TESTING MARKET , BY TECHNOLOGY, 2019–2036 (USD MILLION) 128 TABLE 120 REST OF SOUTH AMERICA: DRIED BLOOD SPOT TESTING MARKET , BY APPLICATION, 2019–2036 (USD MILLION) 128 TABLE 121 REST OF SOUTH AMERICA: DRIED BLOOD SPOT TESTING MARKET , BY END USER, 2019–2036 (USD MILLION) 129 TABLE 122 MIDDLE EAST AND AFRICA DRIED BLOOD SPOT TESTING MARKET , BY COUNTRY, 2019-2036 (USD MILLION) 131 TABLE 123 MIDDLE EAST AND AFRICA:DRIED BLOOD SPOT TESTING MARKET , BY CARD TYPE, 2019–2036 (USD MILLION) 131 TABLE 124 MIDDLE EAST AND AFRICA: DRIED BLOOD SPOT TESTING MARKET , BY TECHNOLOGY, 2019–2036 (USD MILLION) 132 TABLE 125 MIDDLE EAST AND AFRICA: DRIED BLOOD SPOT TESTING MARKET , BY APPLICATION, 2019–2036 (USD MILLION) 132 TABLE 126 MIDDLE EAST AND AFRICA: DRIED BLOOD SPOT TESTING MARKET , BY END USER, 2019–2036 (USD MILLION) 133 TABLE 127 GCC COUNTRIES:DRIED BLOOD SPOT TESTING MARKET , BY CARD TYPE, 2019–2036 (USD MILLION) 133 TABLE 128 GCC COUNTRIES: DRIED BLOOD SPOT TESTING MARKET , BY TECHNOLOGY, 2019–2036 (USD MILLION) 134 TABLE 129 GCC COUNTRIES: DRIED BLOOD SPOT TESTING MARKET , BY APPLICATION, 2019–2036 (USD MILLION) 134 TABLE 130 GCC COUNTRIES: DRIED BLOOD SPOT TESTING MARKET , BY END USER, 2019–2036 (USD MILLION) 135 TABLE 131 SOUTH AFRICA:DRIED BLOOD SPOT TESTING MARKET, BY CARD TYPE, 2019–2036 (USD MILLION) 135 TABLE 132 SOUTH AFRICA: DRIED BLOOD SPOT TESTING MARKET, BY TECHNOLOGY, 2019–2036 (USD MILLION) 136 TABLE 133 SOUTH AFRICA: DRIED BLOOD SPOT TESTING MARKET, BY APPLICATION, 2019–2036 (USD MILLION) 136 TABLE 134 SOUTH AFRICA: DRIED BLOOD SPOT TESTING MARKET, BY END USER, 2019–2036 (USD MILLION) 137 TABLE 135 REST OF MIDDLE EAST AND AFRICA:DRIED BLOOD SPOT TESTING MARKET , BY CARD TYPE, 2019–2036 (USD MILLION) 137 TABLE 136 REST OF MIDDLE EAST AND AFRICA: DRIED BLOOD SPOT TESTING MARKET , BY TECHNOLOGY, 2019–2036 (USD MILLION) 138 TABLE 137 REST OF MIDDLE EAST AND AFRICA: DRIED BLOOD SPOT TESTING MARKET , BY APPLICATION, 2019–2036 (USD MILLION) 138 TABLE 138 REST OF MIDDLE EAST AND AFRICA: DRIED BLOOD SPOT TESTING MARKET , BY END USER, 2019–2036 (USD MILLION) 139 TABLE 139 ACQUISITION 144 TABLE 140 PRODUCT LAUNCH 144 TABLE 141 EXPANSION 144 TABLE 142 AHLSTROM OYJ: PRODUCTS OFFERED 147 TABLE 143 REVVITY INC: PRODUCTS OFFERED 150 TABLE 144 REVVITY INC: KEY DEVELOPMENTS 151 TABLE 145 ARCHIMEDLIFE GMBH: PRODUCTS OFFERED 154 TABLE 146 QIAGEN: PRODUCTS OFFERED 156 TABLE 147 EASTERN BUSINESS FORMS, INC: PRODUCTS OFFERED 159 TABLE 148 RDA SPOT INC.: PRODUCTS OFFERED 162 TABLE 150 SALIMETRICS LLC: KEY DEVELOPMENTS 164 TABLE 151 CYTIVA: PRODUCTS OFFERED 166 TABLE 152 CENTOGENE GMBH: PRODUCTS OFFERED 169 TABLE 153 NEOTERYX, LLC: PRODUCTS OFFERED 171 LIST OF FIGURES FIGURE 1 MARKET ATTRACTIVENESS ANALYSIS: GLOBAL DRIED BLOOD SPOT TESTING MARKET, 2025 20 FIGURE 2 GLOBAL DRIED BLOOD SPOT TESTING MARKET ANALYSIS, BY CARD TYPE, 2025 (USD MILLION AND %) 21 FIGURE 3 GLOBAL DRIED BLOOD SPOT TESTING MARKET ANALYSIS, BY TECHNOLOGY, 2025 (USD MILLION AND %) 22 FIGURE 4 GLOBAL DRIED BLOOD SPOT TESTING MARKET ANALYSIS, BY APPLICATION, 2025 (USD MILLION AND %) 23 FIGURE 5 GLOBAL DRIED BLOOD SPOT TESTING MARKET ANALYSIS, BY END USER, 2025 (USD MILLION AND %) 24 FIGURE 6 GLOBAL DRIED BLOOD SPOT TESTING MARKET ANALYSIS, BY REGION, 2025 (USD MILLION AND %) 25 FIGURE 1 GLOBAL DRIED BLOOD SPOT MARKET: STRUCTURE 27 FIGURE 2 GLOBAL DRIED BLOOD SPOT TESTING MARKET: MARKET GROWTH AFFECTING FACTOR ANALYSIS (2019-2036) 44 FIGURE 3 GLOBAL DRIED BLOOD SPOT TESTING MARKET DRIVER: IMPACT ANALYSIS 47 FIGURE 4 GLOBAL DRIED BLOOD SPOT TESTING MARKET RESTRAINT: IMPACT ANALYSIS 49 FIGURE 5 PORTER'S FIVE FORCES ANALYSIS: GLOBAL DRIED BLOOD SPOT TESTING MARKET 52 FIGURE 6 GLOBAL DRIED BLOOD SPOT TESTING MARKET, CARD TYPE SEGMENT ATTRACTIVENESS, 2025 & 2036 (USD MILLION) 63 FIGURE 7 GLOBAL DRIED BLOOD SPOT TESTING MARKET, BY CARD TYPE, 2025 & 2036 (USD MILLION) 63 FIGURE 8 GLOBAL DRIED BLOOD SPOT TESTING MARKET SHARE (%), BY CARD TYPE, 2025 66 FIGURE 9 GLOBAL DRIED BLOOD SPOT TESTING MARKET, TECHNOLOGY SEGMENT ATTRACTIVENESS, 2025 & 2036 (USD MILLION) 67 FIGURE 10 GLOBAL DRIED BLOOD SPOT TESTING MARKET, BY TECHNOLOGY, 2025 & 2036 (USD MILLION) 67 FIGURE 11 GLOBAL DRIED BLOOD SPOT TESTING MARKET SHARE (%), BY TECHNOLOGY, 2025 69 FIGURE 12 GLOBAL DRIED BLOOD SPOT TESTING MARKET, APPLICATION SEGMENT ATTRACTIVENESS, 2025 & 2036 (USD MILLION) 70 FIGURE 13 GLOBAL DRIED BLOOD SPOT TESTING MARKET, BY APPLICATION, 2025 & 2036 (USD MILLION) 71 FIGURE 14 GLOBAL DRIED BLOOD SPOT TESTING MARKET SHARE (%), APPLICATION, 2025 74 FIGURE 15 GLOBAL DRIED BLOOD SPOT TESTING MARKET, END USER SEGMENT ATTRACTIVENESS, 2025 & 2036 (USD MILLION) 75 FIGURE 16 GLOBAL DRIED BLOOD SPOT TESTING MARKET, BY END USER, 2025 & 2036 (USD MILLION) 76 FIGURE 17 GLOBAL DRIED BLOOD SPOT TESTING MARKET SHARE (%), END USER, 2025 79 FIGURE 18 GLOBAL MARKET ANALYSIS: DRIED BLOOD SPOT TESTINGS MARKET, 2019-2036 (USD MILLION) 80 FIGURE 19 GLOBAL DRIED BLOOD SPOT TESTING MARKET, BY REGION, 2025 (% SHARE) 81 FIGURE 20 NORTH AMERICA MARKET: SWOT ANALYSIS 82 FIGURE 21 NORTH AMERICA DRIED BLOOD SPOT TESTING MARKET, BY REGION, 2025 & 2036 (USD MILLION) 82 FIGURE 22 NORTH AMERICA DRIED BLOOD SPOT TESTING MARKET SHARE (%), BY COUNTRY, 2025 83 FIGURE 23 EUROPE MARKET: SWOT ANALYSIS 88 FIGURE 24 EUROPE DRIED BLOOD SPOT TESTING MARKET, BY REGION, 2025 & 2036 (USD MILLION) 88 FIGURE 25 EUROPE DRIED BLOOD SPOT TESTING MARKET SHARE (%), BY COUNTRY, 2025 89 FIGURE 26 ASIA PACIFIC MARKET: SWOT ANALYSIS 101 FIGURE 27 ASIA PACIFIC DRIED BLOOD SPOT TESTING MARKET, BY REGION, 2025 & 2036 (USD MILLION) 101 FIGURE 28 ASIA PACIFIC DRIED BLOOD SPOT TESTING MARKET SHARE (%), BY COUNTRY, 2025 102 FIGURE 29 SOUTH AMERICA MARKET SWOT ANALYSIS: DRIED BLOOD SPOT TESTING MARKET 118 FIGURE 30 SOUTH AMERICA DRIED BLOOD SPOT TESTING MARKET, BY COUNTRY, 2025 & 2036 (USD MILLION) 118 FIGURE 31 SOUTH AMERICA DRIED BLOOD SPOT TESTING MARKET SHARE (%), BY COUNTRY, 2025 119 FIGURE 32 MIDDLE EAST AND AFRICA MARKET SWOT ANALYSIS: DRIED BLOOD SPOT TESTING MARKET 130 FIGURE 33 MIDDLE EAST AND AFRICA DRIED BLOOD SPOT TESTING MARKET , BY COUNTRY, 2025 & 2036 (USD MILLION) 130 FIGURE 34 MIDDLE EAST AND AFRICA DRIED BLOOD SPOT TESTING MARKET SHARE (%), BY COUNTRY, 2025 131 FIGURE 35 GLOBAL DRIED BLOOD SPOT MARKET PLAYERS: COMPETITIVE ANALYSIS, 2025 141 FIGURE 36 COMPETITOR DASHBOARD: GLOBAL DRIED BLOOD SPOT MARKET 142 FIGURE 37 AHLSTROM OYJ: FINANCIAL OVERVIEW SNAPSHOT 146 FIGURE 38 AHLSTROM OYJ: SWOT ANALYSIS 147 FIGURE 39 REVVITY INC: FINANCIAL OVERVIEW SNAPSHOT 150 FIGURE 40 REVVITY INC: SWOT ANALYSIS 151 FIGURE 41 QIAGEN: FINANCIAL OVERVIEW SNAPSHOT 156 FIGURE 42 QIAGEN: SWOT ANALYSIS 157 FIGURE 43 EASTERN BUSINESS FORMS, INC: SWOT ANALYSIS 159 FIGURE 44 CYTIVA: SWOT ANALYSIS 166

提及公司

Ahlstrom OyjRevvity IncARCHIMEDlife GmbHCENTOGENE GmbHEastern Business FormsIncRDA Spot IncSalimetricsLLCQiagenNeoteryxLLCCytiva (Danaher)

同分類最新報告（醫療與生命科學）

查看醫療與生命科學全部報告 →

量子訊息有限公司為 Market Research Future 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們